(Q34274980)

1 August 2017

title

In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: implications for MS pathogenesis (English)

1 reference

1 August 2017

0 references

Caterina Serra

1

1 reference

1 August 2017

Giuseppe Mameli

2

1 reference

1 August 2017

Giannina Arru

3

1 reference

1 August 2017

Stefano Sotgiu

4

1 reference

1 August 2017

Giulio Rosati

5

1 reference

1 August 2017

Antonina Dolei

6

1 reference

1 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14602576

29 March 2024

publication date

1 December 2003

1 reference

1 August 2017

December 2003

0 references

published in

Journal of NeuroVirology

1 reference

1 August 2017

volume

9

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

637-643

1 reference

https://scigraph.springernature.com/pub.10.1080/13550280390246462

1 August 2017

exact match

0 references

cites work

Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases

1 reference

12 December 2020

Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis

1 reference

12 December 2020

Changes in plasma cytokines induced by interferon-beta1a treatment in patients with multiple sclerosis

1 reference

12 December 2020

Infectious etiology in multiple sclerosis: the debate continues

1 reference

12 December 2020

Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database

1 reference

12 December 2020

Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives

1 reference

12 December 2020

Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis

1 reference

12 December 2020

Nitric oxide metabolites and interleukin-6 in cerebrospinal fluid from multiple sclerosis patients

1 reference

12 December 2020

Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells

1 reference

12 December 2020

Multiple effects of interferon on the replication of human immunodeficiency virus type 1.

1 reference

12 December 2020

IFN-beta-1b inhibits IL-12 production in peripheral blood mononuclear cells in an IL-10-dependent mechanism: relevance to IFN-beta-1b therapeutic effects in multiple sclerosis

1 reference

12 December 2020

The prevalence of multiple sclerosis in the world: an update

1 reference

12 December 2020

Human viral superantigens: to be or not to be transactivated?

1 reference

12 December 2020

Tc1/Tc2 and Th1/Th2 balance in Asian and Western types of multiple sclerosis, HTLV-I-associated myelopathy/tropical spastic paraparesis and hyperIgEaemic myelitis

1 reference

12 December 2020

Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients

1 reference

12 December 2020

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

1 reference

12 December 2020

Gliotoxicity, reverse transcriptase activity and retroviral RNA in monocyte/macrophage culture supernatants from patients with multiple sclerosis

1 reference

12 December 2020

Multiple sclerosis-associated retrovirus and MS prognosis: an observational study

1 reference

12 December 2020

Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and RANTES beta-chemokines

1 reference

12 December 2020

Critical Influences of the Cytokine Orchestration on the Outcome of Myelin Antigen‐Specific T‐Cell Autoimmunity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

1 reference

12 December 2020

Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions.

1 reference

12 December 2020

Opposite effects of IFN-gamma on CCR5 and CXCR4 expression and on entry of M- and T-tropic HIV in epithelial cells.

1 reference

12 December 2020

Influence of infection on exacerbations of multiple sclerosis

1 reference

12 December 2020

Mutual interactions between HIV-1 and cytokines in adherent cells during acute infection

1 reference

12 December 2020

Particle-associated retroviral RNA and tandem RGH/HERV-W copies on human chromosome 7q: possible components of a 'chain-reaction' triggered by infectious agents in multiple sclerosis?

1 reference

12 December 2020

Does a retrovirally encoded superantigen cause multiple sclerosis?

1 reference

12 December 2020

Host factors and the pathogenesis of HIV-induced disease

1 reference

12 December 2020

Interferon-? therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 production

1 reference

12 December 2020

Cytokines in multiple sclerosis: methodological aspects and pathogenic implications

1 reference

12 December 2020

HIV-persistent infection and cytokine induction in mesangial cells: a potential mechanism for HIV-associated glomerulosclerosis

1 reference

12 December 2020

Molecular cloning and characterization of MSRV-related sequences associated with retrovirus-like particles

1 reference

12 December 2020

Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis

1 reference

12 December 2020

Multiple sclerosis and human herpesvirus 6

1 reference

12 December 2020

Balancing the Th1/Th2 concept in multiple sclerosis

1 reference

12 December 2020

Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients

1 reference

12 December 2020

Infection and the etiology and pathogenesis of multiple sclerosis

1 reference

12 December 2020

Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation

1 reference

12 December 2020

Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).

1 reference

12 December 2020

1 reference

12 December 2020

Avoiding false positives with PCR

1 reference

12 December 2020

Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression

1 reference

12 December 2020

10.1080/13550280390246462

Identifiers

DOI

10.1080/714044485

0 references

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14602576

Dimensions Publication ID

29 March 2024

1058426407

0 references

1 reference